SERIES: Patient Medication Information | Number 2 of 4 « Previous | Next »

Oct 12

Past Event

Ensuring Access to Effective Patient Medication Information

Summary

Consumers and patients need information about their medications that is accurate, balanced and delivered in an easily understood format. Unfortunately, recent studies have shown that current systems for delivering prescriptions to consumers consistently fail to fulfill the need for pertinent details.

On October 12, the Engelberg Center for Health Care Reform at Brookings hosted a public forum to discuss strategies for ensuring that patients have access to effective patient medication information (PMI). Through a series of panel discussions, key stakeholders explored patients’ expectations for this information and how they access the details and warnings, along with feasible solutions for delivering higher-quality information to patients.

After each panel, speakers took audience questions.

Event Agenda

  • Welcome, Overview, Key Elements of Effective PMI

    • mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Janet Woodcock

      Director, Center for Drug Evaluation and Research, Food and Drug Administration

  • 9:25 a.m. -- Session I: FDA and Patient Medication Information – The Path Forward

    • Rachel Behrman

      Director, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration

    • Amie O’Donoghue

      Social Science Analyst, Division of Drug Marketing, Advertising, and Communications, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration

  • 10:20 a.m. -- Session II: Patient Perspectives – Making PMI More Effective

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Doris Peter

      Manager, Consumer Reports Health Ratings Center

    • Nancy Hughes

      Assistant Vice President of Communications and Marketing, National Health Council

    • Vanessa Cajina

      Statewide Policy Analyst, California Immigrant Policy Center

    • N. Lee Rucker

      Senior Strategic Policy Advisor, AARP Public Policy Institute

    • James Heywood

      Co-Founder and Chairman, PatientsLikeMe

      d'Arbeloff Founding Director, ALS Therapy Development Institute

  • 12:45 p.m. -- Session III: Effective PMI – The Roles of Manufacturers and PMI Vendors

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Tom Bizarro

      Vice President, Health Policy and Industry Relations, First DataBank

    • Baxter Byerly

      Vice President, Information Technology, Catalina Health Resource

    • Marissa Craddock

      Manager, Labeling, Advertising, and Promotional Materials, Roxane Laboratories, Inc.

    • Freda Lewis-Hall

      Senior Vice President and Chief Medical Officer, Pfizer, Inc.

    • Pamela Budny

      Manager in Regulatory Affairs - Global Scientific Policy, Eli Lilly and Company

  • 2:25 p.m. -- Session IV: Effective Distribution of PMI

    • Moderator

      Portrait:S. Lawrence Kocot
    • William Shrank

      Assistant Professor of Medicine, Harvard Medical School Associate Physician, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital

    • Kate Berry

      Senior Vice President, Strategy and Innovation, Surescripts

      Executive Director, Center for Improving Medication Management

    • Will Lockwood

      Assistant to the Executive Director, American Society for Automation in Pharmacy

    • John Coster

      Senior Vice President, Government Affairs, National Community Pharmacists Association

    • Russell Teagarden

      Vice President, Clinical Practices & Therapeutics, Medco Health Solutions, Inc.

  • 3:50 p.m. -- Recap and Closing Remarks

    • Rachel Behrman

      Director, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration

Details

October 12, 2010

8:30 AM - 4:00 PM EDT

Renaissance Dupont Hotel

New Hampshire Ballroom

1143 New Hampshire Ave. NW

Map

For More Information

Brookings Office of Communications

(202) 797-6105

SERIES: Patient Medication Information | Number 2